10
Views
2
CrossRef citations to date
0
Altmetric
Review

Managing the reproductive health of pediatric and adolescent patients

&
Pages 655-666 | Published online: 10 Jan 2014

References

  • Johnson RE, Newhall WJ, Papp JR et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections: 2002. MMWR Recomm. Rep.51(RR15), 1–38 (2002).
  • Huppert JS, Batteiger BE, Braslins P et al. Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J. Clin. Microbiol.43(2), 684–687 (2005).
  • Blake DR, Duggan A, Quinn T, Zenilman J, Joffe A. Evaluation of vaginal infections in adolescent women: can it be done without a speculum? Pediatrics102(4 Pt 1), 939–944 (1998).
  • Sobel JD. What’s new in bacterial vaginosis and trichomoniasis? Infect. Dis. Clin. North Am.19(2), 387–406 (2005).
  • Braverman PK, Breech L; Committee on Adolescence. American Academy of Pediatrics. Clinical report – gynecologic examination for adolescents in the pediatric office setting. Pediatrics126(3), 583–590 (2010).
  • American College of Obstetricians and Gynecologists: ACOG Committee Opinion No. 292. Primary and preventive care: periodic assessments. Obstet. Gynecol.102, 1117–1124 (2003).
  • U.S. Preventive Services Task Force. Screening for chlamydial infection: recommendation statement. Ann. Intern. Med.147, 128–134 (2007).
  • American College of Obstetricians and Gynecologists (ACOG). Cervical cytology screening. ACOG Practice Bulletin No. 109. Obstet. Gynecol.114, 1409–1420 (2009).
  • Meyers D, Wolff T, Gregory K et al; USPSTF. USPSTF recommendations for STI screening. Am. Fam. Physician77(6), 819–824 (2008).
  • American College of Obstetricians and Gynecologists (ACOG). Committee Opinion No. 467. Human Papillomavirus Vaccination. Obstet. Gynecol.116, 800–803 (2010).
  • U.S. Preventive Services Task Force. Screening for chlamydial infection: recommendation statement. Ann. Intern. Med.147(2), 128–134 (2007).
  • U.S. Preventive Services Task Force. Screening for gonorrhea: recommendation statement. Ann. Fam. Med.3(3), 263–267 (2005).
  • Workowski KA, Berman SM, for the Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm. Rep.55(RR11), 1–94 (2006).
  • American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Primary and preventive care: periodic assessments. Obstet. Gynecol.102(5 Pt 1), 1117–1124 (2003).
  • Arlt W, Willis DS, Wild SH et al. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab.95(11), 5110–5121 (2010).
  • Han TS, Goswami D, Trikudanathan S, Creighton SM, Conway GS. Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. Eur. J. Endocrinol.159(2), 179–185 (2008).
  • Jørgensen KT, Rostgaard K, Bache I et al. Autoimmune disease in women with Turner’s syndrome. Arthritis Rheum.62(3), 658–666 (2010).
  • Bondy CA. Aortic dissection in Turner’s syndrome. Curr. Opin. Cardiol.23(6), 519–526 (2008).
  • Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simón C, Pellicer A. Reproductive impact of congenital Müllerian anomalies. Hum. Reprod.12(10), 2277–2281 (1997).
  • Johannsen TH, Ripa CP, Mortensen EL, Main KM. Quality of life in 70 women with disorders of sex development. Eur. J. Endocrinol.155(6), 877–885 (2006).
  • Pfeifer SM, Gosman GG. Evaluation of adnexal masses in adolescents. Pediatr. Clin. North Am.46(3), 573–592 (1999).
  • van Winter JT, Simmons PS, Podratz KC. Surgically treated adnexal masses in infancy, childhood, and adolescence. Am. J. Obstet. Gynecol.170(6), 1780–1786 (1994).
  • Brown MF, Hebra A, McGeehin K et al. Ovarian masses in children: a review of 91 cases of malignant and benign masses. J. Pediatr. Surg.28(7), 930–933 (1993).
  • Skinner MA, Schlatter MJ, Heifetz SA et al. Ovarian neoplasms in children. Arch. Surg.128(8), 849–853 (1993).
  • Wu A, Siegel MJ. Sonography of pelvic masses in children: diagnostic predictability. AJR Am. J. Roentgenol.148(6), 1199–1202 (1987).
  • Moore JG, Schifrin BS, Erez S. Ovarian tumors in infancy, childhood, and adolescence. Am. J. Obstet. Gynecol.99(7), 913–922 (1967).
  • Ein SH, Darte JM, Stephens CA. Cystic and solid ovarian tumors in children: a 44-year review. J. Pediatr. Surg.5(2), 148–156 (1970).
  • Lee EJ, Kwon HC, Joo HJ et al. Diagnosis of ovarian torsion with color doppler sonography: depiction of twisted vascular pedicle. J. Ultrasound Med.17, 83 (1998).
  • Albayram F, Hamper UM. Ovarian and adnexal torsion: spectrum of sonographic findings with pathologic correlation. J. Ultrasound Med.20(10), 1083–1089 (2001).
  • Pena JE, Ufberg D, Cooney N, Denis AL. Usefulness of Doppler sonography in the diagnosis of ovarian torsion. Fertil. Steril.73(5), 1047–1050 (2000).
  • Oltmann SC, Fischer A, Barber R et al. Cannot exclude torsion – a 15-year review. J. Pediatr. Surg.1212–1216 (2001).
  • Boukaidi SA, Delotte J, Steyaert H et al. Thirteen cases of isolated tubal torsions associated with hydrosalpinx in children and adolescents, proposal for conservative management: retrospective review and literature survey. J. Pediatr. Surg.46(7), 1425–1431 (2011).
  • Dehner LP, Hill DA, Deschryver K. Pathology of the breast in children, adolescents, and young adults. Semin. Diagn. Pathol.16, 235–247 (1999).
  • Simpson JS, Barson AJ. Breast tumours in infants and children: a 40-year review of cases at a children’s hospital. Can. Med. Assoc. J.101, 100–102 (1969).
  • West KW, Rescorla FJ, Scherer LR 3rd, Grosfeld JL. Diagnosis and treatment of symptomatic breast masses in the pediatric population. J. Pediatr. Surg.30, 182–186 (1995).
  • Feig SA. The role of ultrasound in a breast imaging center. Semin. Ultrasound CT MR10, 90–105 (1989).
  • Venta LA, Dudiak CM, Salomon CG, Flisak ME. Sonographic evaluation of the breast. RadioGraphics14, 29–50 (1994).
  • Griffith JR. Virginal breast hypertrophy. J. Adolesc. Health Care10, 423–432 (1989).
  • Fisher W, Smith JW. Macromastia during puberty. Plast. Reconstr. Surg.47, 445–451 (1971).
  • Sridhar GR, Sinha MJ. Macromastia in adolescent girls. Indian Pediatr.32, 496–499 (1995).
  • O’Hare PM, Frieden IJ. Virginal breast hypertrophy. Pediatr. Dermatol.17(4), 277–281 (2000).
  • Mayl N, Vasconez LO, Jurkiewiez MJ. Treatment of macromastia in the actively enlarging breast. Plast. Reconstr. Surg.54, 6–12 (1974).
  • Greydanus DE, Matytsina L, Gains M. Breast disorders in children and adolescents. Prim. Care33, 455–502 (2006).
  • Brook I. Aerobic and anaerobic microbiology of neonatal breast abscesses. Pediatr. Infect. Dis. J.10, 785–786 (1991).
  • Simmons PS. Breast disorders. In: Pediatric and Adolescent Gynecology. Sanfilippo JS, Muram D, Dewhurst J, Lee PA (Eds). Saunders, PA, USA, 583–600 (1994).
  • Elsheikh A, Keramopoulos A, Lazaris D, Ambela C, Louvrou N, Michalas S. Breast tumors during adolescence. Eur. J. Gynaecol.21, 408–410 (2000).
  • Goldstein DP, Miller V. Breast masses in adolescent females. Clin. Pediatr.21, 17–19 (1982).
  • Chung EM, Cube R, Hall GJ, González C, Stocker JT, Glassman LM. From the archives of the AFIP: breast masses in children and adolescents: radiologic–pathologic correlation. Radiographics29(3), 907–931 (2009).
  • Briggs RM, Walters M, Rosenthal D. Cystosarcoma phyllodes in adolescent female patients. Am. J. Surg.146, 712–714 (1983).
  • Rajan PB, Cranor ML, Rosen PP. Cystosarcoma phyllodes in adolescent girls and young women: a study of 45 patients. Am. J. Surg. Pathol.22, 64–69 (1998).
  • Pettinato G, Manivel JC, Kelly DR, Wold LE, Dehner LP. Lesions of the breast in children exclusive of typical fibroadenoma and gynecomastia: a clinicopathologic study of 113 cases. Pathol. Annu.24(2), 296–328 (1989).
  • Ramirez G, Ansfeld FJ. Carcinoma of the breast in childhood. Arch. Surg.96, 222–225 (1968).
  • Sperling M, Rosenfield RL, Cooke DW, Radovick S. The ovary and female maturation. In: Pediatric Endocrinology (3rd Edition). Sperling M (Ed.). Elsevier, PA, USA, 530–609 (2008).
  • Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Arch. Dis. Child44, 291–303 (1969).
  • Herman-Giddens ME, Slora EJ, Wasserman RC et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings Network. Pediatrics99, 505–512 (1997).
  • Herman-Giddens ME, Kaplowitz PB, Wasserman R. Navigating the recent articles on girls’ puberty in pediatrics: what do we know and where do we go from here? Pediatrics113, 911–917 (2004).
  • Wu T, Mendola P, Buck GM. Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988–1994. Pediatrics110, 752–757 (2002).
  • Sun SS, Schubert CM, Chumlea WC et al. National estimates of the timing of sexual maturation and racial differences among US children. Pediatrics110, 911–919 (2002).
  • Kaplowitz PB, Oberfield SE. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: implications for evaluation and treatment. Pediatrics104, 936–941 (1999).
  • Nathan BM, Palmert MR. Regulation and disorders of pubertal timing. Endocrinol. Metab. Clin. North Am.34, 617–641 (2005).
  • Carel JC, Leger J. Precocious puberty. N. Engl. J. Med.358, 2366–2377 (2008).
  • Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab.21, 1440–1447 (1961).
  • Yildiz BO. Diagnosis of hyperandrogenism: clinical criteria. Best Pract. Res. Clin. Endocrinol. Metab.20, 167–176 (2006).
  • Herman-Giddens ME, Slora EJ, Wasserman RC et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network. Pediatrics99, 505–512 (1997).
  • Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil. Steril.90, 219–225 (2008).
  • Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. Am. J. Obstet. Gynecol.140, 371–380 (1981).
  • Deligeoroglou E, Athanasopoulos N, Tsimaris P, Dimopoulos KD, Vrachnis N, Cretsas G. Evaluation and management of adolescent amenorrhea. Ann. NY Acad. Sci.1205, 23–32 (2010).
  • Stein AL, Levenick MN, Kletzky OA. Computed tomography versus magnetic resonance imaging for the evaluation of suspected pituitary adenomas. Obstet. Gynecol.73(6), 996–999 (1989).
  • Harel Z. Approach to the adolescent girl as she transits from irregular to regular menstrual cycles. J. Pediatr. Adolesc. Gynecol.18, 193–200 (2005).
  • Koutras DA. Disturbances of menstruation in thyroid disease. Ann. NY Acad. Sci.816, 280 (1997).
  • Harel Z, Biro F, Kollar L. Depo-Provera in adolescents: effects of early second injection or prior oral contraception. J. Adolesc. Health16, 379 (1995).
  • Smith YR, Quint EH, Hertzberg RB. Menorrhagia in adolescents requiring hospitalization. J. Pediatr. Adolesc. Gynecol.11, 13 (1998).
  • Lusher JM. Screening and diagnosis of coagulation disorders. Am. J. Obstet. Gynecol.175(3 Pt 2), 778–783 (1996).
  • Cowan BD, Morrison JC. Management of abnormal genital bleeding in girls and women. N. Engl. J. Med.324(24), 1710–1715 (1991).
  • Bayer SR, DeCherney AH. Clinical manifestations and treatment of dysfunctional uterine bleeding. JAMA269(14), 1823–1828 (1993).
  • Zhang WY, Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhea: a systematic review. Br. J. Obstet. Gynecol.105, 780–789 (1998).
  • Robinson JC, Plichta S, Weisman CS et al. Dysmenorrhea and use of oral contraceptives in adolescent women attending a family planning clinic. Am. J. Obstet. Gynecol.166, 578–583 (1992).
  • Laufer MR, Goitein L, Bush M et al. Prevalence of endometriosis in adolescent women with chronic pelvic pain not responding to conventional therapy. J. Pediatr. Adolesc. Gynecol.10, 199–202 (1997).
  • Davis GD, Thillet E, Lindemann J. Clinical characteristics of adolescent endometriosis. J. Adolesc. Health14, 362–368 (1993).
  • ACOG Committee Opinion No. 310; American College of Obstetricians and Gynecologists. Endometriosis in adolescents. Obstet. Gynecol.105, 921–927 (2005).
  • Laufer MR, Sanfilippo J, Rose G. Adolescent endometriosis: diagnosis and treatment approaches. J. Pediatr. Adolesc. Gynecol.16(Suppl. 3), S3–S11 (2003).
  • Tasker GL, Wojnarowska F. Lichen sclerosus. Clin. Exp. Dermatol.28, 128–133 (2003).
  • Val I, Almeida G. An overview of lichen sclerosus. Clin. Obstet. Gynecol.48, 808–817 (2005).
  • Marron ML, Esterly NB. Constipation as a feature of anogenital lichen sclerosus in children. Pediatrics115, 230–232 (2005).
  • Poindexter G, Morrell D. Anogenital pruritis: lichen sclerosus in children. Pediatr. Ann.36, 785–791 (2007).
  • Powell J, Wojnarowska F. Childhood vulvar sclerosus: an increasingly common problem. J. Am. Acad. Dermatol.44, 803–806 (2001).
  • Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: the course after puberty. J. Reprod. Med.47, 706–709 (2002).
  • Dei M, Di Maggio F, Di Paolo G, Bruni V. Vulvovaginitis in childhood. Best Pract. Res. Clin. Obstet. Gynaecol.24(2), 129–137 (2010).
  • Fischer G, Rogers M. Vulvar disease in children: a clinical audit of 130 cases. Pediatr. Dermatol.17(1), 1–6 (2000).
  • Stricker T, Navratil F, Sennhausr FH. Vulvovaginitis in prepubertal girls. Arch. Dis. Child.88, 324–326 (2003).
  • Jaquiery A, Stylianopoulos A, Hogg G. Vulvovaginitis: clinical features, aetiology, and microbiology of the genital tract. Arch. Dis. Child.81, 64–67 (1999).
  • Omar HA. Management of labial adhesions in prepubertal girls. J. Pediatr. Adolesc. Gynecol.16(1), 21–23 (2000).
  • Nurzia MJ, Eickhorst KM, Ankem MK et al. The surgical treatment of labial adhesions in pre-pubertal girls. J. Pediatr. Adolesc. Gynecol.16, 21 (2003).
  • Leung AKC, Robson WLM, Kao CP et al. Treatment of labial fusion with topical estrogen therapy. Clin. Pediatrics44(3), 245–247 (2005).
  • Muram D. Treatment of prepubertal girls with labial adhesions. J. Pediatr. Adolesc. Gynecol.12(2), 67–70 (1999).
  • Kempe CH. Sexual abuse, another hidden pediatric problem: the 1977 C Anderson Aldrich lecture. Pediatrics62, 382–389 (1978).
  • Yates A. Differentiating hypererotic states in the evaluation of sexual abuse. J. Am. Acad. Child Adolesc. Psychiatry30, 791–795 (1991).
  • Kellogg N; Committee on Child Abuse and Neglect. The evaluation of sexual abuse in children. Pediatrics116(2), 506–512 (2005).
  • Christian CW, Lavelle JM, DeJong AR et al. Forensic evidence findings in prepubertal victims of sexual assault. Pediatrics106, 100–104 (2000).
  • American Academy of Pediatrics; Committee on Practice and Ambulatory Medicine. The use of chaperones during the physical examination of the pediatric patient. Pediatrics98(6 Pt 1), 1202 (1996).
  • Bays J, Chadwick D. Medical diagnosis of the sexually abused child. Child Abuse Negl.17, 91–110 (1993).
  • Heger A, Emans SJ, Muram D et al.Evaluation of the Sexually Abused Child: A Medical Textbook and Photographic Atlas, (2nd Edition). Oxford University Press, NY, USA (2000).
  • Adams JA, Harper K, Knudson S, Revilla J. Examination findings in legally confirmed child sexual abuse: it’s normal to be normal. Pediatrics94, 310–317 (1994).
  • McCann J, Voris J, Simon M. Genital injuries resulting from sexual abuse: a longitudinal study. Pediatrics89, 307–317 (1992).
  • American Academy of Pediatrics. Sexually transmitted diseases. In: Report of the Committee on Infectious Diseases (26th Edition). American Academy of Pediatrics; Pickering LK (Ed.). Red Book, IL, USA, 157–167 (2003).
  • Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2006. Natl Vital. Stat. Rep.56, 1–18 (2007).
  • Smith CA. Factord associated with early sexual activity among urban adolescents. Soc. Work42, 334–346 (1997).
  • Hewitt G, Cromer B. Update on Adolescent contraception. Obstet. Gynecol. Clin. North Am.27, 143–162 (2000).
  • Lara-Torre E, Schroeder B. Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. Contraception66, 81–85 (2002).
  • Hatcher RA, Trussell J, Nelson AL et al.Contraceptive technology (19th Edition). Kowal D (Ed.). Ardent Media, NY, USA (2007).
  • Stevens-Simon C, Kelly L, Kulick R. A village would be nice but…it takes a long-acting contraceptive to prevent repeat adolescent pregnancies. Am. J. Prev. Med.21(1), 60–65 (2001).
  • Mansour D, Korver T, Marintcheva-Petrova M et al. The effects of Implanon on menstrual bleeding patterns. Eur. J. Contracept. Reprod. Healthcare13(Suppl. 1), 13–28 (2008).
  • Andersson JK, Rybo G. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia. Br. J. Obstet. Gynaecol.97(8), 690–694 (1990).
  • Baldaszti E, Wimmer-Puchinger B, Loschke K. Acceptability of the long-term contraceptive levonorgestrel-releasing intrauterine system (Mirena): a 3-year follow-up study. Contraception67(2), 87–91 (2003).
  • Hidalgo M, Bahamondes L, Perrotti M et al. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception65(2), 129–123 (2002).
  • Shaaban MM, Zakherah MS, El-Nashar SA, Sayed GH. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial. Contraception83(1), 48–54 (2011).
  • Mosher W, Jones J. Use of contraception in the United States: 1982–2008. National Center for Health Statistics. Vital Health Stat.23(29), 1–44 (2010).
  • Fleming KL, Sokoloff A, Raine TR. Attitudes and beliefs about the intrauterine device among teenagers and young women. Contraception Aug 82(2), 178–182 (2010).
  • Godfrey EM, Memmel LM, Neustadt A et al. Intrauterine contraception for adolescents aged 14–18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A. Contraception81(2), 123–127 (2010).
  • Lara-Torre E, Spotswood L, Correia N, Weiss PM. Intrauterine contraception in adolescents and young women: a descriptive study of use, side effects, and compliance. J. Pediatr. Adolesc. Gynecol.24(1), 39–41 (2011).
  • Whitaker AK, Terplan M, Gold MA, Johnson LM, Creinin MD, Harwood B. Effect of a brief educational intervention on the attitudes of young women toward the intrauterine device. J. Pediatr. Adolesc. Gynecol.23(2), 116–120 (2010).
  • Yuzpe AA, Lancee WJ. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive. Fertil. Steril.28, 932–936 (1977).
  • Task Force on Postovulatory Methods of Fertility Regulation. Randomized controlled trial of levenorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet353, 428–432 (1998).
  • Piaggio G, Kapp N, von Hertzen H. Effect on pregnancy rates of the delay in the administration of levonorgestrel for emergency contraception: a combined analysis of four WHO trials. Contraception84(1), 35–39 (2011).
  • Minnis AM, Shiboski SC, Padian NS. Barrier contraceptive method acceptability and choice are not reliable indicators of use. Sex Transm. Dis.30, 556–561 (2003).
  • Hingson RW, Strunin L, Berlin BM et al. Beliefs about AIDS, use of alcohol and drugs and unprotected sex among Massachusetts adolescents. Am. J. Public Health80, 295–299 (1990).
  • Chacko MR, Kozinetz CA, Smith PB. Assessment of oral contraceptive pill continuation in young women. J. Pediatr. Adolesc. Gynecol.12(3), 143–148 (1999).
  • Polaneczky M, Slap G, Forke C et al. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N. Engl. J. Med.331, 1201–1206 (1994).
  • Berenson AB, Wiemann CM. Use of levonorgestrel implants versus oral contraceptives in adolescents: a case-control study. Am. J. Obstet. Gynecol.172, 1128–1135 (1999).
  • Woods ER, Grace E, Havens KK et al. Contraceptive compliance with a levonorgestrel triphasic and a norethindrone monophasic oral contraceptive pill in adolescent patients. Am. J. Obstet. Gynecol.166, 901–907 (1992).
  • Bearss N, Santelli JS, Papa P. A pilot program of contraceptive continuation in six school-based clinics. J. Adolesc. Health17(3), 178–183 (1995).
  • Diclemente R, Wingood G, Crosby R et al. Parental monitoring: association with adolescents’ risk behavior. Pediatrics107, 1363–1368 (2001).
  • Brooks-Gunn J, Furstenburg FF. Adolescent sexual behavior. Am. Psychol.10, 249–257 (1989).
  • Zabin LS, Stark HA, Emerson MR. Reasons for delay in contraceptive clinic utilization: adolescent clinic and nonclinic populations compared. J. Adolesc. Health12, 225–232 (1991).
  • Reddy DM, Fleming R, Swain C. Effect of mandatory parental notification on adolescent girls’ use of sexual health services. JAMA288, 710–714 (2002).
  • Manlove J, Ryan S, Franzetta K. Patterns of contraceptive use within teenagers’ first sexual relationships. Perspect. Sex. Reprod. Health35, 246–255 (2003).
  • Rock EM, Ireland M, Resnick MD. To know that we know what we know: perceived knowledge and adolescent sexual risk behavior. J. Pediatr. Adolesc. Gynecol.16, 369–376 (2003).
  • Emans SJ, Grace E, Woods ER et al. Adolescents’ compliance with the use of oral contraceptives. JAMA257, 3377–3381 (1987).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.